Cargando…

KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear-cell carcinoma cells

Kinesin family member 20A (KIF20A), which is involved in cytokinesis and intracellular transportation, has been recently reported to be upregulated in several malignancies and may contribute to chemotherapeutic resistance. We examined the distribution and expression of KIF20A in clear-cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawai, Yosuke, Shibata, Kiyosumi, Sakata, Jun, Suzuki, Shiro, Utsumi, Fumi, Niimi, Kaoru, Sekiya, Ryuichiro, Senga, Takeshi, Kikkawa, Fumitaka, Kajiyama, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059742/ https://www.ncbi.nlm.nih.gov/pubmed/29749467 http://dx.doi.org/10.3892/or.2018.6401

Ejemplares similares

Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
por: Suzuki, Shiro, et al.
Publicado: (2016)

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
por: Sakata, Jun, et al.
Publicado: (2017)

PRIMA-1(MET) induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells
por: YOSHIKAWA, NOBUHISA, et al.
Publicado: (2016)

Fertility-sparing surgery of malignant transformation arising from mature cystic teratoma of the ovary
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2018)

Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology
por: Kajiyama, Hiroaki, et al.
Publicado: (2014)

The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours
por: Kajiyama, Hiroaki, et al.
Publicado: (2018)

The Therapeutic Effects of Goreisan, a Traditional Japanese Herbal Medicine, on Lower-Limb Lymphedema after Lymphadenectomy in Gynecologic Malignancies: A Case Series Study
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study
por: Adachi, Manabu, et al.
Publicado: (2015)

The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma
por: Kajiyama, Hiroaki, et al.
Publicado: (2020)

Epidemiological overview of metastatic ovarian carcinoma: long-term experience of TOTSG database
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
por: Yoshida, Kosuke, et al.
Publicado: (2019)

Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinoma
por: Utsumi, Fumi, et al.
Publicado: (2014)

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
por: Niimi, Kaoru, et al.
Publicado: (2014)

Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
por: Ukai, Mayu, et al.
Publicado: (2021)

Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: Two case reports
por: Suzuki, Shiro, et al.
Publicado: (2014)

GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth
por: LUO, CHENHONG, et al.
Publicado: (2014)

HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells
por: Yuan, Hong, et al.
Publicado: (2015)

Growing Teratoma Syndrome of the Ovary Showing Three Patterns of Metastasis: A Case Report
por: Shibata, Kiyosumi, et al.
Publicado: (2013)

Estrogen producing ovarian fibrosarcoma: A case report
por: Miura, Mayo, et al.
Publicado: (2019)

The Preoperative Prognostic Nutritional Index for the Prediction of Outcomes in Patients with Early-Stage Ovarian Clear Cell Carcinoma
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Establishment and characterization of cell lines derived from complete hydatidiform mole
por: Yamamoto, Eiko, et al.
Publicado: (2017)

Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells
por: Koya, Yoshihiro, et al.
Publicado: (2018)

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2014)

The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study
por: Yamamoto, Eiko, et al.
Publicado: (2020)

P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling
por: Shibata, Kiyosumi, et al.
Publicado: (2007)

Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity
por: Nakamura, Kenichi, et al.
Publicado: (2021)

Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
por: Terauchi, Mikio, et al.
Publicado: (2007)

Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
por: Tsukamoto, Hirohisa, et al.
Publicado: (2008)

Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma
por: Shimbo, Akiko, et al.
Publicado: (2019)

Expression of the chrXq27.3 miRNA cluster in recurrent ovarian clear cell carcinoma and its impact on cisplatin resistance
por: Yoshida, Kosuke, et al.
Publicado: (2021)

Variable susceptibility of ovarian cancer cells to non-thermal plasma-activated medium
por: UTSUMI, FUMI, et al.
Publicado: (2016)

Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
por: Yoshihara, Masato, et al.
Publicado: (2019)

Future perspective of strategic non-thermal plasma therapy for cancer treatment
por: Kajiyama, Hiroaki, et al.
Publicado: (2017)

Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
por: Nakamura, Kae, et al.
Publicado: (2017)

Effect of Indirect Nonequilibrium Atmospheric Pressure Plasma on Anti-Proliferative Activity against Chronic Chemo-Resistant Ovarian Cancer Cells In Vitro and In Vivo
por: Utsumi, Fumi, et al.
Publicado: (2013)

Non-thermal atmospheric pressure plasma activates lactate in Ringer’s solution for anti-tumor effects
por: Tanaka, Hiromasa, et al.
Publicado: (2016)

Comparison of prognoses according to non‐positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
por: Maeda, Osamu, et al.
Publicado: (2016)

Complete Response of Recurrent Small Cell Carcinoma of the Uterine Cervix to Paclitaxel, Carboplatin, and Bevacizumab Combination Therapy
por: Nakao, Yuri, et al.
Publicado: (2020)

Ovarian cancer‐associated mesothelial cells induce acquired platinum‐resistance in peritoneal metastasis via the FN1/Akt signaling pathway
por: Yoshihara, Masato, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_moes7ms8iq39bb8ra4l3eejb27